Becker's Healthcare May 12, 2022
Medicare Part D spending on top brand-name drugs over a five-year period “more than made up the money” that drugmakers say it costs to develop new medications, according to a May 11 AARP report.
AARP’s Public Policy Institute researched Medicare spending between between 2016 and 2020 on the 10 brand-name drugs the program spent the most on in 2020, according to the report.
The institute’s research found that, on average, Medicare Part D spending was more than five times higher than the average costs to develop a...